Notable’s Post

View organization page for Notable, graphic

3,512 followers

It can take months to determine who will respond to a specific cancer treatment. This is time that many patients and their families simply cannot afford.   Acute myeloid leukemia is a deadly disease and as few as 15% of patients fighting relapsed/refractory AML respond to the current standard of care.    Notable #CSO Joseph Wagner shares his thoughts about unmet medical needs for patients fighting cancer. #AcuteMyeloidLeukemia #AML #cancer

I used to work on ETO.

Like
Reply
Caroline Bone, MS

Director of Business Operations @ Inscripta, Inc. | Operations, Process Improvement

1mo

Well done team! This is great!

Joanna Bueche, PhD

Product & Assay Development Expert | R&D Project Lead | Tech Transfer | QC & Manufacturing Lead | IVD LDT & Flow Cytometry, CRO Operations | Cross-Functional Collaboration, Communication & Mentoring | Animal Charity

4w

Congrats guys!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics